Wednesday, May 04, 2022 9:29:39 AM
Can it run like OS*T IPO?
Recent ACON News
- Aclarion Announces Agreement with Weill Cornell Medicine • GlobeNewswire Inc. • 04/08/2026 12:00:00 PM
- Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video • GlobeNewswire Inc. • 04/07/2026 12:00:00 PM
- Echo Lake Capital Calls for the Resignation of David Neal From the Board of Directors of Aclarion Inc. • ACCESS Newswire • 03/24/2026 12:00:00 PM
- Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan • GlobeNewswire Inc. • 03/19/2026 01:25:40 PM
- Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts • GlobeNewswire Inc. • 03/19/2026 10:00:00 AM
- Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet • GlobeNewswire Inc. • 03/17/2026 10:00:00 AM
- Aclarion CEO Brent Ness to Attend LSI USA 2026 • GlobeNewswire Inc. • 03/12/2026 10:00:00 AM
- Aclarion Publishes 2026 Shareholder Letter from the Chairman • GlobeNewswire Inc. • 02/05/2026 11:00:00 AM
- Aclarion Adds High-Volume Practice, Source Healthcare, to Support Nociscan Growth and Real-World Evidence Generation • GlobeNewswire Inc. • 02/03/2026 11:00:00 AM
- Aclarion Strengthens Balance Sheet and Extends Cash Runway Into 2028 • GlobeNewswire Inc. • 01/13/2026 11:00:00 AM
- Aclarion shares surge after sharp rise in Q4 Nociscan usage • IH Market News • 01/08/2026 03:30:17 PM
- Aclarion Provides 2025 Update and 2026 Corporate Outlook • GlobeNewswire Inc. • 01/08/2026 11:00:00 AM
- Aclarion Announces First Patient Enrollments at Two Additional CLARITY Trial Sites and Provides Guidance on Expected Availability of Initial Data • GlobeNewswire Inc. • 01/06/2026 11:00:00 AM
- Aclarion Shares Move Higher After Nociscan Highlighted in Spine Surgery Journal • IH Market News • 12/04/2025 03:58:32 PM
- Aclarion Announces Publication of Nociscan Article in Special Pain Issue of the International Journal of Spine Surgery (IJSS) • GlobeNewswire Inc. • 12/04/2025 01:00:00 PM
- Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S. • GlobeNewswire Inc. • 12/02/2025 01:00:00 PM
- Aclarion Appoints Dan Isherwood as UK Commercial Director to Drive Adoption and Market Expansion • GlobeNewswire Inc. • 11/05/2025 11:00:00 AM
- Aclarion Wins “Rising Star” at 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH • GlobeNewswire Inc. • 10/22/2025 10:00:00 AM
- Aclarion Provides Corporate Update Highlighting Market Expansion as CLARITY Trial Advances Toward Key Data Catalyst • GlobeNewswire Inc. • 10/14/2025 10:09:47 AM
- Aclarion Announces Use of MR Spectroscopy for identifying Biomarkers of Discogenic Pain highlighted at Global Neuroscience Conference • GlobeNewswire Inc. • 10/13/2025 10:00:00 AM
- Aclarion to Present at the LD Micro Main Event XIX • Newsfile • 10/09/2025 10:00:00 AM
- Aclarion Honored as Finalist for the 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH • GlobeNewswire Inc. • 10/07/2025 10:00:00 AM
- Aclarion Presents at LSI Europe ’25 Highlighting Nociscan Technology and Key Value Drivers • GlobeNewswire Inc. • 10/01/2025 11:17:53 AM
- First Patients Enrolled at UHealth – University of Miami in Aclarion’s Pivotal CLARITY Trial • GlobeNewswire Inc. • 09/25/2025 10:00:00 AM
- Aclarion Appoints Greg Gould as Chief Financial Officer • GlobeNewswire Inc. • 09/03/2025 10:00:00 AM
